Pharmaceutical & Drug Policy
How US tariffs stand to impact prescription drugs
On April 20, the Engelberg Center convened an expert workshop to discuss prescribing information for health care professionals.
This workshop brought together a diverse set of stakeholders who discussed the following issues:
- How the prescribing information (PI) is currently accessed and utilized;
- If the current PI format is meeting the needs of prescribers and other health care professionals and if all PIs should be standardized in this format;
- How PIs could be encouraged as the primary resource for prescription drug information; and
- The content that is most useful for prescribers and other health care providers in the Patient Counseling Information (PCI) section of the PI.
Agenda
-
April 20
-
Welcome, Introduction, and Workshop Objectives
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke UniversityJWJanet Woodcock Director, Center for Drug Evaluation and Research - US Food and Drug Administration -
Session I: Experiences with Prescribing Information
-
Session II: Opportunities to Encourage Clinicians’ Use of Prescribing Information
-
Session III: Experiences with Patient Counseling Information and
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke UniversityRSRachel Sherman Principal, Drug and Biological Drug Products - Greenleaf Health LLCAEAmy EbelDMTDerjung Mimi Tarn David Geffen School of Medicine at UCLAJDJoan Davenport University of Maryland School of NursingSFRSandra F. Ryan Take Care Health SystemsHFHeather Free BioScrip Specialty Pharmacy -
Recap and Closing Remarks
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University
-
